id,evidence_inference_prompt_id,pmcid,outcome,intervention,comparator agent,outcome_type,intervention_events,intervention_group_size,comparator_events,comparator_group_size,intervention_mean,intervention_standard_deviation,comparator_mean,comparator_standard_deviation,standardized_mean_difference,smd_sampling_variance,log_odds_ratio,lor_sampling_variance,log_risk_ratio,lrr_sampling_variance,notes,is_data_complete,openai_gpt_token_num_abstract_results,split,output
,11248,57750,Death or myocardial infarction,eptifibatide,placebo,binary,,,,,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Group sizes are not given so the events cannot calculate using the percentages.,FALSE,"5,811",DEV,"```yaml
intervention:
  events: 847
  group_size: 5475
comparator:
  events: 671
  group_size: 5473
```"
,11249,57750,Myocardial infarction,eptifibatide,placebo,binary,,,,,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Group sizes are not given so the events cannot calculate using the percentages.,FALSE,"5,811",DEV,"```yaml
intervention:
    events: 638
    group_size: x
comparator:
    events: 386
    group_size: x
```"
,10676,3276927,effective in the treatment of reversible inguinal hernia,post-Yoga,pre-Yoga,binary,,19,,19,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,"No real numerical data attached to this specific outcome. Other prompts account for ""treatment",FALSE,"2,011",DEV,"```yaml
intervention:
    events: 19
    group_size: 19	
comparator:
    events: x
    group_size: x
```"
,3102,4450164,ureteropelvic junction obstruction,internal drainage group,stentless cases,binary,8,20,13,44,,,,,,,0.4636,0.3175,0.3029,0.1292,,TRUE,"3,862",DEV,"```yaml
intervention:
    events: 8
    group_size: 30
comparator:
    events: x
    group_size: x
```"
,13818,5244530,sedative prescriptions,person-centred  general practitioners (GP) consultations,treatment as usual (TAU),binary,52,125,51,133,,,,,,,0.1357,0.0647,0.0815,0.0233,Data from 12 months follow up,TRUE,"6,216",DEV,"```yaml
intervention:
    events: 26
    group_size: 125
comparator:
    events: 32
    group_size: 133
```  "
,13818,5244530,sick leave,person-centred  general practitioners (GP) consultations,treatment as usual (TAU),binary,49,125,64,133,,,,,,,-0.3637,0.0637,-0.205,0.0205,,TRUE,"6,216",DEV,"```yaml
intervention:
  events: x
  group_size: x
comparator:
  events: x
  group_size: x
```"
,13819,5244530,continued antidepressants until the 6&nbsp;month,person-centred  general practitioners (GP) consultations,treatment as usual (TAU),binary,86,125,78,133,,,,,,,0.4414,0.0683,0.1597,0.0089,,TRUE,"6,216",DEV,"```yaml
intervention:
  events: 86
  group_size: 125
comparator:
  events: 78
  group_size: 133
```"
,13181,5771543,CGI-I response rate,fluoxetine,placebo,binary,79,101,62,99,,,,,,,0.7622,0.1013,0.2223,0.0088,Adjusted odds ratio of 0.465 is given.,TRUE,"12,534",DEV,"```yaml
intervention:
    events: 79
    group_size: 101
comparator:
    events: 62
    group_size: 99
```"
,13182,5771543,CGI-I response rate,desvenlafaxine,placebo,binary,68,99,62,99,,,,,,,0.2693,0.0901,0.0924,0.0106,Adjusted odds ratio of 0.751 is given.,TRUE,"12,534",DEV,"```yaml
intervention:
  events: 68
  group_size: 115
comparator:
  events: 79
  group_size: 112
```"
,13183,5771543,Treatment-emergent adverse events (TEAEs),"desvenlafaxine, fluoxetine",placebo,binary,69,115,79,112,,,,,,,-0.4675,0.0792,-0.1618,0.0095,,TRUE,"12,534",DEV,"```yaml
intervention:
  events: 69
  group_size: 115
comparator:
  events: 72
  group_size: 112
```"
